By Ian Walker
LONDON--Koninklijke Philips NV (PHIA.AE) said Thursday it will
appeal the jury verdict in the patent infringement lawsuit by
Masimo Corp. (MASI) in the U.S. District Court for the District of
Delaware against Philips.
The lawsuit, which started in 2009, alleges that certain Masimo
patents are infringed by those Philips products which incorporate
the Philips FAST SpO2 pulse oximetry measurement technology--a
non-invasive technology to measure the level of oxygen saturation
in a patient's blood, the Dutch health and well-being company
said.
As part of the decision that Philips will appeal, Masimo was
awarded a compensation of $467 million, it said.
"We are very disappointed in the verdict of the jury and
surprised by the magnitude of the proposed award," Frans van
Houten, Royal Philips' Chief Executive, said.
"Philips intends to pursue all avenues of appeal of this verdict
at both the District and Appellate courts in the U.S.," he
added.
Write to Ian Walker at ian.walker@wsj.com
Subscribe to WSJ: http://online.wsj.com?mod=djnwires